Press Releases
Cyxone announces Rabeximod in Covid-19 Phase 2 trial closed, data to be reported in Q3
14 Jul, 2021 08:41 CESTRegulatoryCyxone and Medical University of Vienna announce collaboration to study broader T20K use in MS
1 Jul, 2021 09:17 CESTRegulatoryCyxone explores expanding into new regions to mitigate potential delay in Covid-19 trial completion
30 Jun, 2021 08:56 CESTRegulatoryMARCyxone appoints Henrik Hang as CFO
9 Jun, 2021 15:51 CESTRegulatoryBulletin from the annual general meeting in Cyxone AB on 3 June 2021
3 Jun, 2021 13:55 CESTRegulatory